GV20TX Trademark

Trademark Overview


On Friday, July 8, 2022, a trademark application was filed for GV20TX with the United States Patent and Trademark Office. The USPTO has given the GV20TX trademark a serial number of 97494463. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, July 31, 2024. This trademark is owned by GV20 Therapeutics LLC. The GV20TX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of genetic diseases

Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; software as a service services (SAAS) featuring artificial intelligence software for drug discovery and development
gv20tx

General Information


Serial Number97494463
Word MarkGV20TX
Filing DateFriday, July 8, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, July 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of genetic diseases
Pseudo MarkGV TWO ZERO TX; GV TWENTY TX
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; software as a service services (SAAS) featuring artificial intelligence software for drug discovery and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 27, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGV20 Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02139

Party NameGV20 Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, July 12, 2022NEW APPLICATION ENTERED
Wednesday, July 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 24, 2023ASSIGNED TO EXAMINER
Friday, April 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, September 22, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 1, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 29, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 22, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 29, 2024SOU EXTENSION 1 FILED
Monday, January 29, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU EXTENSION 2 GRANTED
Wednesday, July 31, 2024SOU EXTENSION 2 FILED
Wednesday, January 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED